Protease inhibitors block hormonal activation of adenylate cyclase.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002772:Cholera Toxin / Q000037:antagonists & inhibitors; D006063:Chorionic Gonadotropin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D004789:Enzyme Activation / Q000187:drug effects*; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D008565:Membrane Proteins / Q000378:metabolism; D010053:Ovary / Q000201:enzymology*; D011480:Protease Inhibitors; D051381:Rats; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D006063:Chorionic Gonadotropin; D008565:Membrane Proteins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D014108:Tosylphenylalanyl Chloromethyl Ketone; D014106:Tosylarginine Methyl Ester; D002772:Cholera Toxin; D002918:Chymotrypsin; D000262:Adenylyl Cyclases; D005459:Fluorides; D004837:Epinephrine